Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Prevention of Postoperative Urinary Retention in Hysterectomy
NCT05540977Phase 1Unknown
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Aug 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of donepezil in urinary retention (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: The incidence of urinary retention (residual urine volume < 100ml) at 6 weeks. Status: unknown.
02
Drugs
donepezil
03
Conditions
urinary retention
Beyond the preview
Go deeper on NCT05540977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05540977.